GSN and amyloidosis: In this work we have described a practical and drug discovery suitable approach to study in vitro the aggregation kinetics of the main amyloidogenic polypeptide in Finnish gelsolin amyloidosis, the 70-residue gelsolin fragment AGelD187N 173–242.